🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is being done with people with HIV infection who have low levels...
Status
Completed
Location
Alabama Therapeutics CRS (5801)
Start Date
2011-11
Trial ID
NCT01426438
Treatments Being Tested
This is a 12-Week clinical trial in patients with Primary hypercholesterole...
Status
Completed
Location
Multiple Locations
Start Date
2007-07
Trial ID
NCT00479388
Treatments Being Tested
Background: \- Niacin is a vitamin in many foods, including meats, fish, f...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2015-03-25
Trial ID
NCT02322203
Treatments Being Tested
This study is being done to find out if tablets containing extended release...
Status
Terminated
Location
Multiple Locations
Start Date
2011-02-04
Trial ID
NCT01294683
This study is a pilot study examining the effect of extended-release niacin...
Status
Completed
Location
University of Hawaii - Hawaii Center for AIDS
Start Date
2007-11
Trial ID
NCT00986986
Treatments Being Tested
Peripheral arterial disease (PAD) occurs when arteries become narrowed or h...
Status
Completed
Location
Baylor College of Medicine
Start Date
2004-04
Trial ID
NCT00687076
Laropiprant (LRP; Merck \& Co., Inc, Whitehouse Station, NJ, USA) is a pote...
Status
Terminated
Location
Leviev Heart Center, Sheba Medical Center
Start Date
2010-07
Trial ID
NCT01052311
Treatments Being Tested
This phase II, open-label research study was conducted in 129 healthy volun...
Status
Completed
Location
University of Pennsylvania
Start Date
2006-03
Trial ID
NCT00359281
Treatments Being Tested
The primary purpose of this study was to evaluate the psychometric characte...
Status
Completed
Location
Multiple Locations
Start Date
2008-02
Trial ID
NCT00630877
Intermediate saphenous vein graft (SVG) lesions are common, have high rates...
Status
Completed
Location
VA North Texas Healthcare System
Start Date
2010-10
Trial ID
NCT01221402
Treatments Being Tested